|
Volumn 49, Issue , 1997, Pages 57-65
|
Immunomodulation of Crohn's disease by Interleukin-10
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE;
INTERLEUKIN 1;
INTERLEUKIN 10;
INTERLEUKIN 6;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN PRESENTATION;
ANTIGEN PRESENTING CELL;
AUTOIMMUNITY;
B LYMPHOCYTE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEVER;
HEADACHE;
HEMATOPOIETIC CELL;
HUMAN;
HUMAN EXPERIMENT;
IMMUNOMODULATION;
INTRAVENOUS DRUG ADMINISTRATION;
MACROPHAGE FUNCTION;
MOUSE;
MULTICENTER STUDY;
NAUSEA;
NEUTROPHIL;
NONHUMAN;
NORMAL HUMAN;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE;
THERAPY;
ANIMALS;
CROHN DISEASE;
DISEASE MODELS, ANIMAL;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
INTERLEUKIN-10;
MICE;
|
EID: 0030813116
PISSN: 03790363
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (22)
|
References (19)
|